⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KOD News
Kodiak Sciences Inc Common Stock
Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences
prnewswire.com
KOD
Form 8-K
sec.gov
KOD
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
prnewswire.com
KOD
Form 8-K
sec.gov
KOD
Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham
prnewswire.com
KOD
Cobalt Alloy Powder Market to Grow at a CAGR of 4.46% Through 2032, Amid Rising Aerospace Demand and High-Performance Material Applications | Vyansa Intelligence
prnewswire.com
KOD
IAB Connected Commerce Summit to Highlight the Path for Scalable, Sustainable Commerce Media
prnewswire.com
CRTO
DV
UBER
UL
GILD
KOD
Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026
prnewswire.com
KOD
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
prnewswire.com
KOD
Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
prnewswire.com
KOD